13F reference period
Q2 2026
Security Snapshot
BIODESIX INC - Common Stock, par value $0.001 per share (BDSX) Institutional Ownership
CUSIP: 09075X207
13F Institutional Holders and Ownership History from Q3 2025 to Q3 2026
Institutions Reporting
44
Shares (Excl. Options)
4.08M
Full value: 4,082,229 · shares · 30 Jun 2026Price
$22.55
The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.
Save this security page for your next review
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Symbol
- BDSX on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 4,082,229
- Total 13F value
- $92,055,760
- Portfolio coverage rank
- 0%
- Share change
- +467,667
- Value change
- +$10,953,331
- Number of holders
- 44
- Shares outstanding
- 10,298,843
- SEC-reported price per share
- $29.83
- Insider filing price
- $29.83
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source
Key facts
- BDSX - BIODESIX INC - Common Stock, par value $0.001 per share is tracked under CUSIP 09075X207.
- 44 institutions reported positions in Q2 2026.
- 3 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 39 to 44 between Q1 2026 and Q2 2026.
- SEC-reported value moved from to
$52.42M
Full value: $52,422,954 · USD · 31 Mar 2026.$92.06M
Full value: $92,055,760 · USD · 30 Jun 2026
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 44 institutions filings for Q2 2026.
Security key
09075X207
13F reference period
Q2 2026
13F holders
44
13D/G owners
3
CIK / CUSIP context first
Open Q2 2026 holders
BDSX full holder history
BIODESIX INC SEC filings
BIODESIX INC company facts
BIODESIX INC insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 09075X207:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
3
Security
BDSX
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| SCHULER JACK W | 24% | -11% | $15,872,226 | +$1,240,871 | 2,333,945 | +8.5% | SCHULER JACK W | 23 Jan 2026 |
| Soleus Capital Master Fund, L.P. | 5.1% | -20% | $7,973,158 | +$383,158 | 525,241 | +5% | Soleus Capital Master Fund, L.P. | 17 Jun 2026 |
| Telemark Asset Management, LLC | 5.4% | +32% | $2,909,460 | +$680,060 | 427,824 | +31% | Telemark Asset Management, LLC | 22 Jan 2026 |
As of 30 Jun 2026,
44
institutional investors reported holding
shares of
BIODESIX INC - Common Stock, par value $0.001 per share (BDSX).
This represents
40%
of the company’s total
outstanding shares.
4.08M
Full value: 4,082,229 · shares · 30 Jun 202610.3M
Full value: 10,298,843 · shares · Stored outstanding share count13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
38%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| AIGH Capital Management LLC | 6.6% | 678,328 | -11% | 1.4% | $15,296,296 |
| Soleus Capital Management, L.P. | 5.7% | 585,958 | +41% | 0.46% | $13,213,353 |
| Telemark Asset Management, LLC | 4.8% | 489,824 | 0% | 0.8% | $11,045,531 |
| Aberdeen Group plc | 3.8% | 388,639 | -15% | 0.01% | $8,763,809 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.8% | 284,169 | +11% | 0% | $6,408,011 |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 2.3% | 241,915 | +83% | 0.71% | $5,455,183 |
| Opaleye Management Inc. | 1.7% | 180,000 | -24% | 0.37% | $4,059,000 |
| MARSHALL WACE, LLP | 1.1% | 116,199 | -18% | 0% | $2,620,291 |
| PERCEPTIVE ADVISORS LLC | 1.1% | 108,694 | 0.04% | $2,451,049 | |
| JANE STREET GROUP, LLC | 0.89% | 91,506 | +239% | 0% | $2,063,460 |
| TWO SIGMA INVESTMENTS, LP | 0.84% | 86,824 | +92% | 0% | $1,957,881 |
| Legato Capital Management LLC | 0.79% | 81,381 | +98% | 0.15% | $1,835,142 |
| Walleye Capital LLC | 0.72% | 74,447 | +587% | 0.01% | $1,678,780 |
| STEMPOINT CAPITAL LP | 0.68% | 70,000 | -0.01% | 0.27% | $1,578,500 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.66% | 67,657 | +35% | 0% | $1,526,702 |
| Trexquant Investment LP | 0.56% | 57,972 | -17% | 0.01% | $1,307,269 |
| GSA CAPITAL PARTNERS LLP | 0.46% | 46,989 | +19% | 0.07% | $1,060,000 |
| PERKINS CAPITAL MANAGEMENT INC | 0.43% | 44,618 | -0.37% | 0.76% | $1,006,136 |
| BlackRock, Inc. | 0.42% | 43,026 | +76% | 0% | $970,236 |
| BLAIR WILLIAM & CO/IL | 0.4% | 41,548 | +51% | 0% | $936,907 |
| VANGUARD FIDUCIARY TRUST CO | 0.39% | 39,959 | +39% | 0% | $901,075 |
| SEI INVESTMENTS CO | 0.36% | 37,295 | -13% | 0% | $841,002 |
| UBS Group AG | 0.29% | 29,908 | -19% | 0% | $674,426 |
| RENAISSANCE TECHNOLOGIES LLC | 0.28% | 28,648 | +140% | 0% | $646,012 |
| BANK OF AMERICA CORP /DE/ | 0.26% | 26,738 | 0% | $602,942 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
5
Headline period
Q2 2026
Rows shown
1-5 of 5
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q3 | 234,963 | $7,008,947 | -$220,230 | $29.83 | 3 |
| 2026 Q2 | 4,082,229 | $92,055,760 | +$10,953,331 | $22.55 | 44 |
| 2026 Q1 | 3,615,368 | $52,422,954 | +$34,087,127 | $14.50 | 39 |
| 2025 Q4 | 1,342,428 | $9,128,098 | +$1,239,023 | $6.80 | 25 |
| 2025 Q3 | 1,148,993 | $8,674,797 | +$8,674,797 | $7.55 | 25 |